Literature DB >> 12586836

Identification of a region of beta-amyloid precursor protein essential for its gelatinase A inhibitory activity.

Shouichi Higashi1, Kaoru Miyazaki.   

Abstract

Because beta-amyloid precursor protein (APP) has the abilities both to interact with extracellular matrix and to inhibit gelatinase A activity, this molecule is assumed to play a regulatory role in the gelatinase A-catalyzed degradation of extracellular matrix. To determine a region of APP essential for the inhibitory activity, we prepared various derivatives of APP. Functional analyses of proteolytic fragments of soluble APP (sAPP) and glutathione S-transferase fusion proteins, which contain various COOH-terminal parts of sAPP, showed that a site containing residues 579-601 of APP(770) is essential for the inhibitory activity. Moreover, a synthetic decapeptide containing the ISYGNDALMP sequence corresponding to residues 586-595 of APP(770) had a gelatinase A inhibitory activity slightly higher than that of sAPP. Studies of deletion of the NH(2)- and COOH-terminal residues and alanine replacement of internal residues of the decapeptide further revealed that Tyr(588), Asp(591), and Leu(593) of APP mainly stabilize the interaction between gelatinase A and the inhibitor. We also found that the residues of Ile(586), Met(594), and Pro(595) modestly contribute to the inhibitory activity. The APP-derived decapeptide efficiently inhibited the activity of gelatinase A (IC(50) = 30 nm), whereas its inhibitory activity toward membrane type 1 matrix metalloproteinase was much weaker (IC(50) = 2 microm). The decapeptide had poor inhibitory activity toward gelatinase B, matrilysin, and stromelysin (IC(50) > 10 microm). The APP-derived inhibitor formed a complex with active gelatinase A but not with progelatinase A, and the complex formation was prevented completely by a hydroxamate-based synthetic inhibitor. Therefore, the decapeptide region of APP is likely an active site-directed inhibitor that has high selectivity toward gelatinase A.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12586836     DOI: 10.1074/jbc.M212264200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor.

Authors:  Hiroshi Hashimoto; Tomoka Takeuchi; Kyoko Komatsu; Kaoru Miyazaki; Mamoru Sato; Shouichi Higashi
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

2.  Cholesterol sulfate alters substrate preference of matrix metalloproteinase-7 and promotes degradations of pericellular laminin-332 and fibronectin.

Authors:  Kazuhiro Yamamoto; Kaoru Miyazaki; Shouichi Higashi
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

Review 3.  Proteolytic degradation of amyloid β-protein.

Authors:  Takaomi Saido; Malcolm A Leissring
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

4.  Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis.

Authors:  Pallavi Garg; Matam Vijay-Kumar; Lixin Wang; Andrew T Gewirtz; Didier Merlin; Shanthi V Sitaraman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-02       Impact factor: 4.052

5.  Computational insights into the selectivity mechanism of APP-IP over matrix metalloproteinases.

Authors:  Lingling Geng; Jian Gao; Wei Cui; Yancheng Tang; Mingjuan Ji; Bozhen Chen
Journal:  J Comput Aided Mol Des       Date:  2012-12-09       Impact factor: 3.686

Review 6.  Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy.

Authors:  Alex Y Strongin
Journal:  Biochim Biophys Acta       Date:  2009-05-04

Review 7.  Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature.

Authors:  A K Chow; J Cena; R Schulz
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

8.  Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2).

Authors:  Shouichi Higashi; Tomokazu Hirose; Tomoka Takeuchi; Kaoru Miyazaki
Journal:  J Biol Chem       Date:  2013-02-10       Impact factor: 5.157

Review 9.  Thoracic aortic dissection: are matrix metalloproteinases involved?

Authors:  Xiaoming Zhang; Ying H Shen; Scott A LeMaire
Journal:  Vascular       Date:  2009 May-Jun       Impact factor: 1.285

Review 10.  Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.

Authors:  Andriy Yabluchanskiy; Yonggang Ma; Rugmani Padmanabhan Iyer; Michael E Hall; Merry L Lindsey
Journal:  Physiology (Bethesda)       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.